Shandong Xinhua Pharmaceutical: Non-Executive Director Xu Lie Steps Down Upon Retirement

Bulletin Express

03/31

Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing retirement due to age.

The company confirmed that Xu Lie has no disagreements with the Board and is unaware of any matters needing shareholder or Hong Kong Stock Exchange attention. Following his departure, Xu Lie no longer holds any position within the group.

Current board composition is as follows:

• Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning, Cheung Ching Ching, Daisy • Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue • Non-executive Director: Zhang Chengyong

The Board expressed appreciation for Xu Lie’s contributions during his tenure.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1133003254"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133003254\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133003254?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133003254","market":"us","top_or_hot":-1,"title":"Shandong Xinhua Pharmaceutical: Non-Executive Director Xu Lie Steps Down Upon Retirement","media":"Bulletin Express","content":"<p>Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing retirement due to age.</p>\n<p>The company confirmed that Xu Lie has no disagreements with the Board and is unaware of any matters needing shareholder or Hong Kong Stock Exchange attention. Following his departure, Xu Lie no longer holds any position within the group.</p>\n<p>Current board composition is as follows:</p>\n<p>• Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning, Cheung Ching Ching, Daisy  \n• Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue  \n• Non-executive Director: Zhang Chengyong</p>\n<p>The Board expressed appreciation for Xu Lie’s contributions during his tenure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharmaceutical: Non-Executive Director Xu Lie Steps Down Upon Retirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharmaceutical: Non-Executive Director Xu Lie Steps Down Upon Retirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-31 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing retirement due to age.</p>\n<p>The company confirmed that Xu Lie has no disagreements with the Board and is unaware of any matters needing shareholder or Hong Kong Stock Exchange attention. Following his departure, Xu Lie no longer holds any position within the group.</p>\n<p>Current board composition is as follows:</p>\n<p>• Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning, Cheung Ching Ching, Daisy  \n• Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue  \n• Non-executive Director: Zhang Chengyong</p>\n<p>The Board expressed appreciation for Xu Lie’s contributions during his tenure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00719","symbol_name":"山东新华制药股份","start_time":0,"source_url":"","article_id":"1133003254","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133003254","pubTimestamp":1774946672,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00719":"山东新华制药股份"},"translate_title":"山东新华制药：非执行董事徐烈退休离任","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00719":1},"content_text":"Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing retirement due to age.\nThe company confirmed that Xu Lie has no disagreements with the Board and is unaware of any matters needing shareholder or Hong Kong Stock Exchange attention. Following his departure, Xu Lie no longer holds any position within the group.\nCurrent board composition is as follows:\n• Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning, Cheung Ching Ching, Daisy  \n• Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue  \n• Non-executive Director: Zhang Chengyong\nThe Board expressed appreciation for Xu Lie’s contributions during his tenure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}